Purpose: To characterize seizure types and electroencephalographic features of glucose transporter type 1 deficiency syndrome (Glut-1 DS).
Glucose transporter type 1 deficiency syndrome (Glut-1 DS) was initially described in 1991 by De Vivo et al. (1) in two children with developmental delay, infantile seizures, and hypoglycorrhachia. Since that time, >80 children have been identified with this disorder. The condition results from a loss of functional glucose transporters, encoded by GLUT-1, that mediate glucose transport across the blood-brain barrier. This defect leads to a reduction in the CSF/blood glucose ratio to approximately one half of normal, and a reduction in CSF lactate (2) . As D-glucose is the predominant fuel for brain metabolism, impaired cerebral function results.
Identification of children with this syndrome requires recognition of characteristic clinical features (developmental delay, ataxia, hypotonia, infantile seizures, acquired microcephaly) in association with a reduced CSF glucose concentration. A high level of suspicion should be maintained in individuals with epilepsy in the absence of the classic phenotype, as more subtle forms of Glut-1 DS have been reported (3) . The laboratory hallmark is hypoglycorrhachia with an absolute CSF glucose <40 mg/dl. The diagnosis can be confirmed by blood testing, as the Glut-1 transporter protein also mediates glucose transport into erythrocytes (4) . The GLUT-1 gene was initially mapped to the short arm of chromosome 1 (1p31. 3-p35) , and more recently to 1p34.2 (5) . Molecular analysis of GLUT-1 in affected individuals has demonstrated a variety of mutations in this region (6, 7) . In addition, three families with autosomal dominant transmission of Glut-1 DS have been identified (3, 8, 9) .
Although the occurrence of seizures often brings children with Glut-1 DS to medical attention, limited information is available regarding the seizure types or EEG features seen with this syndrome. In 1999, Boles et al. (10) described two affected children with atypical absence seizures and generalized paroxysmal 2-to 2.5-Hz spike-wave discharges on video-EEG monitoring. Von Moers et al. (11) recently studied two children with Glut-1 DS, comparing pre-and postprandial EEG recordings. The fasting background EEG in both children was described as mild to moderately slow, with multifocal and generalized high-amplitude irregular spikes and spike-waves. A significant reduction in epileptiform discharges was noted in the postprandial EEG recordings.
More than a decade after identification of Glut-1 DS, the clinical, EEG, and genetic features continue to be defined and revised. Although it is a rare disorder, increased awareness and testing for Glut-1 DS will likely increase the prevalence of this syndrome. Recognition is important for management of the seizures, as they are poorly controlled by antiepileptic medications (AEDs) (1) . Initiation of the ketogenic diet provides an alternative cerebral energy source, leading to improvements in seizure control (2, 11) . Further characterization of the epilepsy syndrome will better enable the clinician to make an early diagnosis and initiate appropriate treatment.
CASE HISTORY
This boy, now age 8 years, was recently diagnosed with Glut-1 DS. Pregnancy was term and uncomplicated, with a birth weight of 3,316 g. Family history did not reveal consanguinity or a history of neurologic conditions. Initial developmental milestones were normal, with global developmental delays emerging as he matured. His neurologic symptoms dated back to age 3 months, when his parents observed an exaggerated startle with stiffening of the arms and legs, and fine trembling accompanied by "eyes that would dance around." These episodes lasted Յ30 s and occurred only when he was supine. They could not be provoked. These startles were initially infrequent, and then they began to occur in clusters several times per week.
At age 5 months, episodes of lateral head swaying developed, with wandering of the eyes "as if unable to focus." The total duration was ∼5 min, and the boy would respond to his mother's voice by smiling during the event. At this time, he was hospitalized for evaluation. A routine EEG, a brain magnetic resonance imaging (MRI), and a cervical spine MRI were reported as normal. His diagnostic workup included screening for occult neuroblastoma [computed tomography (CT) of chest and abdomen, and 24-h urine collection for catecholamines], serum amino acids, ammonia, very long chain fatty acids, biotinidase, chromosomal analysis, lysosomal screening, urine oligosaccharides, urine organic acids, urine glycosaminoglycans, and a cardiology consultation (ECG, ECHO, and Holter monitor) because of an intermittent, faint systolic murmur. All of these tests were normal except for a mild elevation of ethylmalonate and methylmalonate in urine organic acids, and a mild elevation of branched-chain amino acids with serum amino acids. After an episode of hypoglycemia with an intercurrent gastroenteritis, a fasting glucose (40 mg/dl) and urine testing were performed with an increase in acylcarnitine esters and lethargy at the end of the fast. A skin biopsy was unremarkable.
At age 2 years, episodes of head drops and eyes jerking upward developed, lasting 1-2 s. The events were most prominent when he was hungry or fatigued, with improvement after eating. An EEG showed "bisynchronous 2-to 4-Hz spike-wave discharges," and ethosuximide (ESM) was started. Topiramate (TPM) was later added because of daily seizures.
By age 7 3 ⁄4 years, he continued to have frequent episodes of head drops. A lumbar puncture revealed a low glucose of 30 mg/dl (serum glucose, 81 mg/dl) and a low-normal lactic acid of 1.1 mM compatible with a diagnosis of Glut-1 DS. At this time, his examination revealed a head circumference of 50.5 cm/<3% (prior measurement of 44.2 cm/∼25% at 7 months old); weight, 17 kg/<3%; and height, 111 cm/<3%. No abnormalities were found on general physical examination. Neurologically, significant delays were observed in cognition and behavior. He was nonverbal with poor oral coordination. No abnormalities of the cranial nerves or ocular fundi were noted. He had mild dystonic posturing of the limbs, particularly when held in a standing position, and assumed a decorticate limb posture when lying in bed. Stance and ambulation were abnormal and performed with assistance only. Truncal incoordination and impairment of rapid alternating movements were present. A rebound phenomenon was observed on cerebellar testing. Muscle bulk, tone, and strength were decreased. Tendon reflexes were increased (3+), and Babinski signs were present bilaterally.
A continuous EEG was performed at our institution before starting the ketogenic diet at age 8 years. The study showed mild diffuse background slowing, and infrequent generalized spike and polyspike-wave complexes activated by drowsiness and sleep. Multiple clinical seizures were observed with generalized myoclonic jerks and an ictal correlate of a 2-to 2.5-Hz frontal predominant spike-wave discharge without lateralizing features ( Fig. 1 ). After initiation of the ketogenic diet, no further seizures were observed. His parents find that he is more alert, with mild improvements in neurologic symptoms.
METHODS

Patients
The 20 children enrolled in the study were diagnosed with Glut-1 DS at our institution (Columbia University) based on the following clinical features and laboratory data: seizures, developmental delay, microcephaly, hypoglycorrhachia (CSF glucose value, <40 mg/dl), de-creased 3-O-methyl-D-glucose (3-OMG) uptake in erythrocytes (∼46 ± 8% of normal control), and heterozygous mutation(s) identified by fluorescence in situ hybridization (FISH) or direct DNA sequencing of polymerase chain reaction (PCR) fragments amplified from the coding area and the intron-exon boundaries of the GLUT-1 gene. All of the previously mentioned clinical features were present in each patient. The blood glucose values, CSF glucose values, 3-OMG uptake, and the heterozygous mutations from these 20 patients are summarized in Table 1 . Laboratory data and 24-h continuous EEG data were gathered on these children as part of a study approved by the Columbia University Institutional Review Board.
Case history and EEG data
Charts were reviewed to determine seizure history, medication trials, response to ketogenic diet, and seizure classification. The results of routine EEG studies from outside institutions were obtained by chart review. The continuous 24-h EEG studies were performed by using the 10-20 international system for electrode placement and were reviewed by an epileptologist at our institution.
RESULTS
Clinical history
The clinical features of the 20 children studied are summarized in Table 2 . The presenting seizure was typi-
FIG. 1.
Myoclonic seizure. The EEG shows a generalized spike-wave discharge with phase reversal at F3, F4 that is clinically associated with a myoclonic jerk of both arms. TCCTGCCCACCACGCTCACCACC  14  83  27  43  T310I  15  97  32  56  857T>G, 858G>A, 858+1del10  16  90  30  34  1157+30del30   a   17  80  28  43  888insG  18  86  34  43  R333W  19  74  32  59  742insC  20  74  36  39  R333W 3-OMG, 3-O-methyl-D-glucose; NA, not available. a No mutation found in the coding area and the intron-exon boundaries of GLUT-1 gene. A 30-nucleotide deletion was found in intron 9. The initial two introns (>12 kb) were not sequenced because of large size. The pathogenicity of this intron deletion remains under investigation.
b Reported blood glucose value was normal, with a low CSF glucose value. Actual numbers not available.
cally characterized as a generalized tonic-clonic seizure, or as a cyanotic or apneic episode. In six of these children, paroxysmal events were detected before the diagnosis of seizures. These events were characterized as abnormal eye movements (4) and behavioral arrests (2) . Seizures continued to be observed in all individuals after the initial seizure; the seizure types are detailed in Table  2 . In addition, other paroxysmal events described included episodes of chaotic eye movements, hemiparesis, unsteadiness, or lethargy. All of the children were started on AEDs after seizure diagnosis, with phenobarbital (PB) being the most common medication choice. In all of the individuals, the caretakers reported continued seizures with AEDs despite multiple medication trials. All of the caretakers reported a decrease or resolution of seizures in their child after starting the ketogenic diet.
Summary of 24-h EEG data
When the 24-h continuous EEG was performed, more than half of the children had not had recent seizures by parental report. The majority of the studies were performed while the children were on the ketogenic diet; however, eight studies were performed before initiation of the diet, and one study was performed 4 years after the discontinuation of the ketogenic diet. These data are summarized in Table 3 . Generalized spike-wave or polyspike-wave discharges were observed during more than half of the 24-h continuous EEGs. Typically these discharges ranged from 2 to 3 Hz, although faster frequencies (3-4 Hz.) were occasionally observed (Fig. 2) . A partial seizure was observed in an 8-week-old boy with Glut-1 DS. The seizure was clinically described as multifocal clonic jerks of the extremities. Electrographically, it began with a rhythmic discharge at the left parietal region with spread to the contralateral hemisphere (Fig.  3) . Sequential continuous EEG monitoring studies were performed in 11 subjects (Table 4) .
Age-related EEG changes
Reports of 42 routine EEG studies from outside institutions were reviewed. Table 5 illustrates the age-related EEG characteristics. Forty routine EEG studies in children 0-8 years (median age, 0.71 years) were analyzed in 
FIG. 2. A/B.
Irregular frontal predominant spike-wave discharges in a 10 year-old boy with Glut-1 DS. C. Generalized 2 Hz. spike-wave discharges followed by frontal predominant slowing occurring during hyperventilation in a 6 year-old girl with Glut-1 DS. 2c. Generalized 2 Hz. spike-wave discharges followed by frontal predominant slowing occurring during hyperventilation in a 6 year-old girl with Glut-1 DS.
combination with 24 continuous 24-h EEG studies of the same age group (median, 4.25 years). The results are illustrated in Figure 4 . Based on the initial data, it was hypothesized that focal features would be more prevalent in EEG studies from children younger than 2 years, and generalized features more common in those of the older child. Pearson's 2 analysis was applied [ 2 (1) ‫ס‬ 2.892; p < 0.10], revealing a trend toward this association (n ‫ס‬ 29). Of the 64 combined routine and continuous EEG studies, 34 were performed before initiation of the ketogenic diet, and 30 were performed while the child was on the ketogenic diet. The distributions of normal and abnormal EEG studies in association with use of the ketogenic diet are detailed in Figure 5 . The differences between the two groups were not statistically significant [ 
DISCUSSION
The epilepsy syndrome associated with Glut-1 DS has not been well described, although seizures remain a prominent clinical feature. Analysis of the CSF/blood glucose ratio has been the primary tool for initial diagnosis of Glut-1 DS. An increased knowledge of the clinical spectrum of Glut-1 DS will assist clinicians in screening and identifying susceptible individuals. Unfortunately, attempts to better understand the seizure types and EEG features with Glut-1 DS are restricted by its low incidence and the relatively recent discovery of this syndrome. For these reasons, several limitations in our study included the small sample size, the reliance on routine EEG studies interpreted at other institutions, and the absence of pre-and postketogenic diet EEG studies in all individuals. Despite these limitations, several clinical and electrographic features were observed.
A normal interictal background remains the most common finding on both routine and prolonged EEG recordings in all age groups. In serial EEG studies in the same individuals, the presence or absence of epileptiform discharges varied. This is observed in individuals with known epilepsy and may reflect an artifact of sampling (12, 13) . Within our study group, a higher proportion of abnormalities is seen in the 24-h data compared with the routine EEGs. Because of the age difference between the two populations, a direct comparison cannot be made, although a sampling bias may contribute to this observation. In addition, variability of the EEG technical quality and interpretation between institutions may be present. As this syndrome is recognized earlier, it is our hope that more rigorous evaluation of the EEG and natural history in Glut-1 DS will be possible.
During childhood (2 years or older), the most common EEG abnormalities were 2.5-to 4-Hz generalized spikeor polyspike-wave discharges. As this EEG pattern is often a marker of idiopathic generalized epilepsy (IGE), this may lead to a delayed diagnosis of Glut-1 DS in a patient with "IGE" who is not responding to AED treatment. In our study population, both absence and myoclonic seizures were observed during 24-h continuous monitoring. Given this combination of EEG features and seizure types, Glut-1 DS should be considered in the differential diagnosis of childhood absence epilepsy or juvenile myoclonic epilepsy, particularly if atypical features are present. In infancy (younger than 2 years), generalized spikewave discharges were less frequent. When abnormalities were present, a trend toward focal slowing or epileptiform discharges was observed. This time point was chosen based on radiologic evidence that myelination approaches that of an adult by 18 months to 2 years (14) . This age-related expression of epilepsy has been demonstrated in animal models. Kindling, changes in myelination, alterations in cell properties, and changes in neurotransmission have been proposed as possible explanations (15) .
Although the age at seizure diagnosis in our patient group ranged from 4 weeks to 18 months, paroxysmal events, such as behavioral arrest and eye-movement abnormalities, were detected earlier and may have represented subtle seizures. In addition, episodes of transient hemiparesis, erratic eye movements, lethargy, and unsteadiness have been observed in older children. Although these events could be related to seizure activity or a postictal "Todd's phenomenon," they also may represent distinct manifestations of Glut-1 transporter dysfunction. Similar nonepileptic events have been observed in paroxysmal neurologic disorders of childhood, such as movement disorders, hemiplegic migraines, periodic paralysis, and alternating hemiplegia of childhood. Each of these disorders has been suggested to share similar mechanisms with epilepsy (16) (17) (18) .
The ketogenic diet remains the best treatment for the seizure disorder and encephalopathy. In addition to providing an alternative energy source for children with Glut-1 DS, the ketogenic diet is thought to have a secondary effect on cerebral glucose transport (19) . In 1975, Gjedde and Crone (20) investigated glucose transport into the brains of rats and demonstrated a 5% increase in the brain-uptake index of glucose during starvation. The anticonvulsant effects of the ketogenic diet are well known and have been investigated in animal models (21) . Appleton and De Vivo (22) compared electroconvulsive thresholds in rats on a high-fat diet with those on a high-carbohydrate diet and found that the stimulus needed to produce a convulsive response was significantly higher with the animals on the high-fat diet.
Some affected children continue to have seizures and/ or developmental delay despite treatment with the ketogenic diet. As the Glut-1 transporter is multifunctional, allowing passage for galactose, water, glycopeptides, and dehydroascorbic acid, deficiencies of other substrates could contribute to the pathophysiology of this syndrome (23) . Mechanisms to increase the number or function of the Glut-1 transporters may be a treatment option in the future. Thioctic acid, an antioxidant that translocates Glut-1 from intracellular pools to the plasma membrane in vitro, is being investigated as a therapeutic agent. Barbiturates, such as PB, and methylxanthines, such as caffeine and theophylline, should be avoided as they are known Glut-1 inhibitors (24, 25) . In the subset of Glut-1 DS patients followed up in our institution, 68% were treated initially with PB (D.C.D., personal observation). As more is learned about the solutes transported through Glut-1 and their effects on cerebral metabolism, additional therapeutic options may become available.
Early identification of children with Glut-1 DS remains important to prevent treatment with AEDs that may be ineffective or potentially detrimental, and to initiate an alternative energy source during a time of in- creased cerebral metabolism. Other metabolic and genetic etiologies of epilepsy and developmental delay should be included in the differential diagnosis, with the evaluation tailored to the presenting clinical features (26) . We recommend that screening no longer be limited to those individuals with the classic phenotype, as milder cases have been described. A diagnostic lumbar puncture and serum glucose level should be considered in all individuals with idiopathic or cryptogenic epilepsy that is not easily controlled with AEDs.
